Ignacio Gómez‐Centurión

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

Ignacio Gómez‐Centurión, Rebeca Bailén, Mariana Bastos‐Oreiro et al. · Clinical Case Reports · 2022 · 43 citations · Full text

Life Sciences, Immunology, Pathology +16

Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation

Rebeca Bailén, Mi Kwon, María Jesús Pascual-Cascón et al. · Annals of Hematology · 2020 · 39 citations

Pharmacy, Immunology, Pharmacotherapy +13

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

Paula Muñiz, Cristina Andrés-Zayas, Diego Carbonell et al. · Frontiers in Immunology · 2022 · 29 citations · Full text

Medicine, Hematology, Immunogenetics +16

Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

Santiago Osorio, Vicente Escudero‐Vilaplana, Ignacio Gómez‐Centurión et al. · Annals of Hematology · 2018 · 26 citations

Medicine, Oncology, Pharmacology +17

Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina

Paulino Álvarez, Fernando Bril, Verónica Castro et al. · International Journal of Risk & Safety in Medicine · 2013 · 25 citations

Medicine, Internal Medicine, Clinical Medicine +11